Deprescribing: Less Is More

This activity offers Medication Safety CE credit. 

Program Description

Polypharmacy and potentially inappropriate medications impact patient health and quality of life by increasing the risk for adverse drug reactions and drug-drug interactions. This may result in direct health consequences, like cognitive impairment and functional decline, increased healthcare-related costs, and higher rates of mortality. As medication experts, pharmacists are well positioned to be catalysts of deprescribing efforts. This program will discuss the impact of inappropriate prescribing, common barriers to deprescribing efforts, and effective strategies and approaches for pharmacists to improve patient outcomes and quality of life.

Target audience: Health-system pharmacists and retail pharmacists

Type of activity: Knowledge
Release date: September 16, 2022
Expiration date: September 16, 2023

Time to complete activity: 2.0 hours
Fee: Free

Educational Objectives

At the completion of this activity, participants will be able to:

• Analyze the harms of inappropriate prescribing and the impact of deprescribing on patient outcomes
• Recognize prime opportunities for deprescribing efforts, including patient characteristics and high-risk medication classes
• Identify barriers to deprescribing and examine available tools, resources, and strategies to facilitate the deprescribing process

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 2.0 contact hours (0.20 CEU) under the ACPE universal activity number 0290-0000-22-439-H05-P. The activity is available for CE credit through September 16, 2023.

Instructions for Completing the Activity and Receiving CPE Credit

To receive CPE credit, participants must complete the pretest, review the activity in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.

Disclosures

The following contributors have no relevant financial relationships with commercial interests to disclose:

Faculty

Kimmy Nguyen, PharmD, BCACP, BC-ADM, TTS

Pharmacy Times Continuing Education™

Planning Staff—Jim Palatine, RPh, MBA; Maryjo Dixon, RPh; Karleen Melody, PharmD; Crissy Wilson; Susan Pordon; Brianna Winters; and Chloe Taccetta

An anonymous peer reviewer was used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.

Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.

For questions about this internet CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms